Beacon Pointe Advisors LLC Makes New $3.02 Million Investment in HCA Healthcare, Inc. $HCA

Key Points

• Beacon Pointe Advisors initiated a roughly $3.02 million position in HCA Healthcare during the second quarter, buying 7,730 shares. Institutional investors and hedge funds collectively own 62.73% of the company.
• Analysts maintain a generally positive view, with a consensus rating of “Moderate Buy” and an average price target of $462.64, although several firms recently lowered their targets.
• HCA exceeded quarterly earnings and revenue expectations, reporting $7.59 in EPS and $20.23 billion in revenue, up 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, yielding approximately 0.7%.

Beacon Pointe Advisors LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 7,730 shares of the company's stock, valued at approximately $3,018,000.

Several other large investors also recently added to or reduced their stakes in HCA. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in HCA Healthcare during the second quarter valued at $9,445,000. Rakuten Investment Management Inc. acquired a new stake in shares of HCA Healthcare during the second quarter worth approximately $9,992,000. RB Capital Management LLC acquired a new stake in shares of HCA Healthcare during the 2nd quarter valued at $1,115,000. Glenview Trust Co acquired a new stake in HCA Healthcare during the second quarter valued at $494,000. Finally, Empowered Funds LLC acquired a new position in HCA Healthcare in the 2nd quarter worth about $9,426,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently commented on HCA. UBS Group dropped their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research note on Monday, July 27th. Barclays decreased their price target on HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating for the company in a research note on Monday, July 27th. Truist Financial decreased their target price on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research report on Monday, July 27th. JPMorgan Chase & Co. decreased their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating for the company in a report on Thursday, August 20th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $435.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $462.64.

HCA Healthcare Trading Down 0.4%

Shares of HCA Healthcare stock opened at $417.57 on Friday. The firm's 50-day moving average price is $401.08 and its two-hundred day moving average price is $441.46. The stock has a market capitalization of $90.40 billion, a price-to-earnings ratio of 13.98, a P/E/G ratio of 1.45 and a beta of 1.10. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. HCA Healthcare's revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.84 earnings per share. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's payout ratio is 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source